Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
Headache: The Journal of Head and Face Pain, 10/14/09
Cady RK et al. – Elevation of saliva calcitonin gene–related peptide (CGRP) is predictive of responsiveness to rizatriptan. In the rizatriptan responsive population, CGRP levels are elevated beginning with the premonitory period and throughout mild and moderate/severe headache. Successful response to rizatriptan correlated with return of saliva CGRP levels to near baseline (interictal) values.
Related Articles
New drugs for migraine
The Journal of Headache and Pain, 10/05/09
Relevance Score: 88%
Study Could Change How Migraines are Diagnosed
Internet Source, 10/02/09
Relevance Score: 88%
Expanding Access to Triptans: Assessment of Clinical Outcome
Headache: The Journal of Head and Face Pain, 10/12/09
Relevance Score: 80%
Calcitonin gene-related peptide, adrenomedullin and flushing
Maturitas, 10/16/09
Relevance Score: 79%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 69%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
European Journal of Pain, 12/18/09
A randomised comparison of regular oral oxycodone and intrathecal morphine for post-caesarean analgesia
International Journal of Obstetric Anesthesia , 12/18/09
Increased pain sensitivity in alcohol withdrawal syndrome
European Journal of Pain, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


